The design of clinical trials and the volume of pharmacogenomics data being generated present challenges to the development and success of future treatment options.
Irwin W. Tischler, DO, suggests that an adaptive approach to clinical trial design can accelerate the development of new agents. He explains that having the capability to modify the design of a trial based upon preliminary results, on an as-you-go basis, may help speed the clinical trial process. For example, based on initial data, the dose of a drug used might be changed during the course of the trial, or the patient population might be modified to include patients who would benefit most.
Dr Tischler adds that pharmacogenetic testing is associated with financial challenges. He explains that testing often involves more than 200 genetic markers; however, only 20 genetic markers are presently actionable. Thus, large amounts of money are being invested on information that is not clinically relevant.
Watch our related Peer Exchange, Oncology Stakeholder Summit 2014: Evidence-Based Decisions to Improve Quality and Regulate Costs
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More